In cancer cells, treatment with selinexor provokes the nuclear accumulation and enhanced activity of many tumor suppressor factors, including p21CIP/WAF1, p27KIP1, p53, p73, BRCA 1/2, RB, and FOXO proteins (Mahipal and Malafa 2016). Here, CDKN1B is linked to cancer.